India is often referred to as the “Pharmacy of the World,” supplying APIs and generic medicines to over 200 countries. One of the key reasons behind this global trust is India’s strong pharmaceutical manufacturing infrastructure, supported by advanced R&D, skilled manpower, and large-scale production capabilities.
Indian API manufacturers produce a wide range of molecules across therapeutic segments such as cardiology, diabetology, oncology, anti-infectives, and CNS. These APIs are supported by essential regulatory documentation, including DMF, COA, and GMP certificates, making them suitable for international registration and import.
Generic medicines manufactured in India offer the same therapeutic effectiveness as branded alternatives, while remaining cost-efficient. This makes India an ideal sourcing destination for distributors and hospital procurement teams in Russia and CIS countries seeking reliable and sustainable pharmaceutical supply solutions.